Total
0
Shares
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon
Managing Director, Fleta Solomon
Source: AUManufacturing
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Little Green Pharma (LGP) signs five-year agreement to distribute its cannabis medicines into Poland
  • A subsidiary of what is regarded as Poland’s largest healthcare operator will hold exclusive distribution rights for LGP’s medicinal cannabis oil and THC flower products
  • Broadly, LGP said the distribution partnership represents another “key plank” in expanding its European sales platform
  • Little Green Pharma shares closed today’s session up 2.33 per cent to trade at 66 cents.

Little Green Pharma (LGP) has inked a five-year agreement to distribute LGP’s cannabis medicines into Poland.

Under the deal, Little Green Pharma is set to supply Pelion SA subsidiary Medezin with its medicinal cannabis oil and high THC flower products for distribution into the country.

Pelion SA is regarded as the largest operator in the Polish and Lithuanian healthcare sector and touts an annual revenue of zł10 billion (approximately A$3.5 billion).

Medezin will hold exclusive rights to distribute LGP medicinal cannabis products — subject to meeting certain sales hurdles — and is targeting sales of at least 20 per cent of the Polish medicinal cannabis oil market and at least 10 per cent of the Polish high-THC medicinal cannabis flower market.

According to LGP, the financial value of the agreement will be subject to final order numbers under the agreement, which in turn are subject to the minimum order requirement.

Broadly, LGP said the distribution partnership represents another “key plank” in expanding its European sales platform.

LGP Managing Director Fleta Solomon said the company was pleased to be partnering with Medezin.

“Our distribution agreement with Medezin reflects LGP’s strategic ambition to
acquire and maintain a substantial share of the Total Addressable Market in
each jurisdiction we supply,” she said.

Little Green Pharma shares closed today’s session up 2.33 per cent to trade at 66 cents.

LGP by the numbers
More From The Market Herald
Dimerix (ASX:DXB) - Managing Director and CEO, Nina Webster

" Dimerix (ASX:DXB) expands DMX-200 study into Australia

Dimerix (DXB) has entered an agreement with the NHMRC Clinical Trials Centre at the University of Sydney to expand the CLARITY 2.

" ACCC scrambles to halt Virtus Health’s (ASX:VRT) purchase of Healius (ASX:HLS) IVF clinics

The ACCC has taken “a significant step” as it seeks an urgent injunction to stop Virtus Health’s (VRT) proposed acquisition of Adora Fertility
IDT Australia (ASX:IDT) - Chair, Alan Fisher

" IDT Australia (ASX:IDT) signs manufacturing deal with Monash University

IDT Australia (IDT) has entered a master services agreement and services order with Monash University.
Prescient Therapeutics (PTX) - CEO and MD, Steven Yatomi Clarke

" Prescient Therapeutics (ASX:PTX) to present new OmniCAR data at conference

Prescient Therapeutics (PTX) will present new results for its OmniCAR drug at the Cell & Gene Meeting on Mesa in California.